药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201222617491814.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文盐酸黄酮哌酯处方资料(仅供参考)
盐酸黄酮哌酯片 (FLAVOXATE HYDROCHLORIDE TABLETS) 【适用症】 盐酸黄酮哌酯片适用于以下疾病引起的尿频、尿急、尿痛、排尿困难及尿失禁等症状: 1.下尿路感染性疾病(前列腺炎、膀胱炎、尿道炎等)。 2.下尿路梗阻性疾病(早、中期前列腺增生症,痉挛性、功能性尿道狭窄)。 3.下尿路器械检查后或手术后(前列腺摘除术、尿道扩张、膀胱腔内手术)。 4.尿道综合征。 5.急迫性尿失禁。
【注意事项】 1.泌尿生殖道感染患者,需进行抗感染治疗。。 2.青光眼、白内障及残余尿量较多者慎用。 3.勿与大量维生素C或钾盐合用。 4.司机及高空作业人员等禁用。
【用法与用量】 口服:一次0.2g,一日3~4次或遵医嘱。
【禁忌症】 1.胃肠道梗阻或出血、贲门失弛缓症、尿道阻塞失代偿者禁用。 2.有神经精神症状者及心、肝、肾功能严重受损者禁用。
【儿童用药注意事项】 12岁以下儿童不宜服用。
【孕妇、哺乳期妇女用药注意事项】 尚未获得孕妇使用后的研究资料,因而孕妇慎用。
【不良反应】 个别患者可出现胃部不适、恶心、呕吐、口渴、嗜睡、视力模糊、心悸及皮疹等。
【药物相互作用】 尚不明确。
【药理】 平滑肌松弛药。具有抑制腺苷酸环化酶、磷酸二酯酶的作用以及拮抗钙离子作用,并有弱的抗毒蕈碱作用,对泌尿生殖系统的平滑肌具有选择性解痉作用,因而能直接解除泌尿生殖系统平滑肌的痉挛,使肌肉松弛,消除尿频、尿急、尿失禁及尿道膀胱平滑肌痉挛引起的下腹部疼痛。
【药物代谢动力学】 据文献报道,盐酸黄酮哌酯片脂溶性较高,口服吸收很快,一次口服0.2g,2小时左右血药浓度即达高峰,它与血浆蛋白结合很少,其水溶性代谢产物3-甲基黄酮-8-羧酸与血浆蛋白结合率高,一次口服后血中t1/2为50分钟,其主要经尿排泄,t1/2约为24小时。代谢产物有3-甲基黄酮-8-羧酸、哌啶醇及羟化产物,原形药很少,还有少量药物从胆汁排泄。
【性状】 糖衣片,除去糖衣后显白色。
【贮藏】:密闭,在阴凉干燥处保存。
Brand Name Urispas
Common Name flavoxate
DIN (Drug Identification Number) 00728179 URISPAS 200MG TABLET
How does this medication work? What will it do for me? Flavoxate belongs to the class of medications called antispasmodics. This medication is used to treat painful urination, urgency of urination, frequent urination at night, and incontinence. These symptoms may result from catheter use or conditions such as cystitis, prostatitis, urethritis, urethrocystitis, and urethrotrigonitis.
Flavoxate works by decreasing muscle spasms in the urinary tract and bladder. Beneficial effects on the bladder muscles may occur as quickly as 2 to 3 hours after taking the medication.
Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. As well, some forms of this medication may not be used for all of the conditions discussed here. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.
Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take this medication if their doctor has not prescribed it.
How should I use this medication? The usual recommended dose for adults and adolescents over 12 years is flavoxate 200 mg 3 or 4 times a day.
It is best to take these tablets after meals.
Many things can affect the dose of a medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
It is important to take this medication exactly as prescribed by your doctor. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Store this medication at room temperature, protect it from light and moisture, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
What form(s) does this medication come in? This medication is available as a 200 mg tablet.
Who should NOT take this medication? Flavoxate should not be taken by anyone who: is allergic to flavoxate or to any of the ingredients of the medication is under 12 years of age has a blockage of the lower urinary tract has a swallowing disorder called achalasia has obstruction of the stomach or intestines has stomach bleeding
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201222617491814.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- |